1. Wang, Yan, Luo, Shiyong, Wang, Yuxuan, Zhong, Weide, Liu, Sihong. 2022. EID3 Promotes Cancer Stem Cell-Like Phenotypes in Osteosarcoma through the Activation of PI3K-AKT Signaling Pathway. In Oxidative medicine and cellular longevity, 2022, 5941562. doi:10.1155/2022/5941562. https://pubmed.ncbi.nlm.nih.gov/36071872/
2. Zhang, Ping, Zhang, Longsheng, Yu, Li, Wang, Ningling, Zhu, Hui. 2024. EP300-interacting inhibitor of differentiation 3 is required for spermatogenesis in mice. In Andrology, , . doi:10.1111/andr.13800. https://pubmed.ncbi.nlm.nih.gov/39551708/
3. Lu, Yu, Zhang, Xiaobo. 2022. Radiochemotherapy-induced DNA repair promotes the biogenesis of gastric cancer stem cells. In Stem cell research & therapy, 13, 481. doi:10.1186/s13287-022-03165-8. https://pubmed.ncbi.nlm.nih.gov/36153608/
4. Diao, Peng-Yu, Li, Shao-Xun, Peng, Jin, Zhao, Hua-Fu, Huang, Guo-Dong. 2020. Overexpression of EP300-interacting inhibitor of differentiation 3 predicts poor prognosis in patients with glioblastoma multiforme. In International journal of clinical and experimental pathology, 13, 979-988. doi:. https://pubmed.ncbi.nlm.nih.gov/32509069/
5. Luo, Liang, Chen, Wen-Jin, Yin, James Q, Xu, Ru-Xiang. 2017. EID3 directly associates with DNMT3A during transdifferentiation of human umbilical cord mesenchymal stem cells to NPC-like cells. In Scientific reports, 7, 40463. doi:10.1038/srep40463. https://pubmed.ncbi.nlm.nih.gov/28074931/